Avai Bio (AVAI) Total Current Liabilities (2018 - 2026)

Avai Bio has disclosed Total Current Liabilities across 9 years of filings, most recently posting $4.0 million for Q2 2026.

• In Q2 2026, Total Current Liabilities rose 87.87% year-over-year to $4.0 million; the TTM figure through Jun 2026 stood at $4.0 million (up 87.87% YoY), while the FY2026 annual figure was $3.4 million, up 89.41% from the prior year.
• Total Current Liabilities came in at $4.0 million for Q2 2026 at Avai Bio, up from $3.4 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $4.0 million in Q2 2026 to a low of $758471.0 in Q3 2022.
• Average Total Current Liabilities over 5 years is $1.9 million, with a median of $1.8 million recorded in 2024.
• Year-over-year, Total Current Liabilities fell 24.78% in 2022 and surged 105.26% in 2023.
• Over 5 years, Total Current Liabilities stood at $824372.0 in 2022, then jumped by 105.26% to $1.7 million in 2023, then soared by 36.54% to $2.3 million in 2024, then climbed by 28.43% to $3.0 million in 2025, then soared by 35.28% to $4.0 million in 2026.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $4.0 million in Q2 2026, $3.4 million in Q1 2026, and $3.0 million in Q4 2025.